
Isofol | ISO-CC-007
NCT03750786
JCP058
A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer (AGENT)
Status:
On Hold

III
Phase

1st
Line of Therapy

Advanced / Metastatic
Disease Stage

Biomarker(s)
N/A
Investigational
Product
Arfolitixorin
Treatment Arms
o Experimental: Group A
ARFOX and Bevacizumab
o Active Comparator: Group B
mFOLFOX-6 and Bevacizumab